Hydrophilic Polymer-Coated Sorbents for Native ADC DAR Separation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current chromatography columns do not provide sufficient resolution of Antibody-Drug Conjugate (ADC) component species, which is crucial for improving product quality, efficacy, and safety in ADCs.

Innovation Solution

A chromatographic stationary phase with a polymer coating comprising a copolymer of hydrophilic monomers, such as 2-Hydroxyethyl methacrylate and Methyl methacrylate, covalently attached to a solid support, allowing for improved separation and resolution of ADCs under mass spectrometry-compatible conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current chromatography columns are used for ADC analysis, then the analysis can be performed, but the resolution of ADC component species is insufficient

Engineering Contradiction:
Improveresolution of ADC component speciesVSAvoidproduct quality assessment
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent changes the chemical composition parameters of the stationary phase by incorporating specific hydrophilic monomers (2-hydroxyethyl methacrylate, N-acryloyl morpholine) in defined ratios with crosslinking agents. This parameter optimization enables baseline resolution of ADC species with DAR values of 0-8, directly improving measurement precision for product quality assessment

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The stationary phase uses a composite polymer coating formed by copolymerization of multiple monomers including hydrophilic monomers, crosslinking agents, and functional monomers. This composite material structure provides both the necessary resolution for ADC separation and the stability required for reliable product quality assessment

Inventive Principle:
Principle #40Composite materials

2Measurement precision

If denaturing conditions are used for ADC separation, then separation can be achieved, but the antibody structure is altered and direct MS coupling is prevented

Engineering Contradiction:
Improveseparation resolutionVSAvoidcompatibility with mass spectrometry
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent creates a non-denaturing inert environment in the stationary phase through the use of hydrophilic monomers and controlled crosslinking that maintains antibody native structure. This allows ADCs to be separated based on DAR values while remaining intact for direct coupling to mass spectrometry, preserving both separation resolution and MS compatibility

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

Solution Approach 2:

The stationary phase parameters are optimized to maintain physiological conditions (pH, ionic strength) that preserve antibody native conformation. The copolymer composition and crosslinking density are specifically tuned to provide separation without denaturation, enabling direct MS coupling for enhanced data quality

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution enables retention of native antibody and baseline resolution of ADCs with varying Drug-to-Antibody Ratios (DARs) without denaturation, facilitating direct coupling to MS for online operations and enhancing data quality.

Implementation Method 1

chromatography compositions and methods for separation of biomolecules, in particular, stationary phases and chromatography columns for improved separation and resolution of ADCs

Methodology Applied
Scientific EffectChromatography: Chromatography

Data Source

PatentUS20260070001A1Composition of chromatographic sorbents and methods for analysis of antibody drug conjugates
Publication Date: 2026.03.12 PHENOMENEX INC
  • US20260070001A1 patent drawing
  • US20260070001A1 patent drawing
  • US20260070001A1 patent drawing

AI summary

The present disclosure provides chromatography compositions and methods for separation of biomolecules, in particular, stationary phases and chromatography columns for improved separation and resolution of DAR species in antibody drug conjugates (ADCs). In one example, a method comprises: (a) exposing the sample to a chromatographic stationary phase of a reverse phase chromatography column, and (b) applying an eluent to the chromatography column to elute the DAR species of antibody-drug conjugate in their native state, wherein the chromatographic stationary phase comprises: a solid support; and a polymer coating on a surface of the solid support; wherein the polymer coating comprises a copolymer comprising a first hydrophilic monomer and a second hydrophilic monomer, wherein the first hydrophilic monomer and second hydrophilic monomer have different hydrophilicity, wherein the copolymer has a tuned hydrophilicity determined by a molar ratio of the first hydrophilic monomer to the second hydrophilic monomer.